Division of Pharmacy & Optometry

Search results

• Biologics registers for immune-mediated inflammatory diseases: enhancing access to novel therapies and balancing drug safety concerns versus effectiveness

  Hyrich, K. (Participant), Bruce, I. (Participant), Griffiths, C. (Participant), Warren, R. (Participant), Symmons, D. (Participant), Ashcroft, D. (Participant), Dixon, W. (Participant), Lunt, M. (Participant), Yiu, Z. (Participant) & (Participant)

  Impact: Health and wellbeing

• Community pharmacy: improving access to medicines and pharmacists

  (Participant), (Participant), (Participant), (Participant), Schafheutle, E. (Participant), Ashcroft, D. (Participant), Bradley, F. (Participant) & Elvey, R. (Participant)

  Impact: Health impacts

• Creation of SkinBiotherapeutics PLC

  (Corresponding participant) & Mcbain, A. (Participant)

  Impact: Economic, Health and wellbeing

• Dosing for groups of patients who were not served previously by conventional drug information.

  Rostami-Hochaghan, A. (Participant)

  Impact

• Drug Development: Influences on Regulatory Policies and Industrial Practices

  (Participant), Houston, J. (Participant), Aarons, L. (Participant), Galetin, A. (Participant) & Rostami-Hodjegan, A. (Participant)

  Impact: Health impacts

• Macular pigment measurement in humans: a new instrument, the Macular Pigment Screener (MPS)

  Murray, I. (Participant), (Participant), Koh, H. H. (Participant), (Participant) & (Participant)

  Impact: Economic impacts, Health impacts, Societal impacts, Technological impacts

• Modernising Drug Development Practices for Precision Dosing in Diverse Patient Populations

  Rostami-Hochaghan, A. (Participant), Aarons, L. (Participant), Galetin, A. (Participant), Barber, J. (Participant), Ogungbenro, K. (Participant) & (Participant)

  Impact: Technological impacts, Economic, Health and wellbeing, Policy

• Molecular markers and drug development leading to improvements in radiotherapy.

  Stratford, I. (Participant), Williams, K. (Participant), West, C. (Participant), (Participant), (Participant), Eustace, A. (Participant) & (Participant)

  Impact: Health impacts

• Quality in community pharmacy services

  Jacobs, S. (Participant)

  Impact

• Reducing prescribing errors and improving patient safety in primary and secondary health care.

  (Participant), Ashcroft, D. (Participant), (Participant), Lewis, P. (Participant), (Participant), (Participant), Eden, M. (Participant) & (Participant)

  Impact: Health impacts

• Revalidation of pharmacy professionals

  Jacobs, S. (Participant)

  Impact

• Safety considerations for graphene: lessons learnt from carbon nanotubes.

  Bussy, C. (Participant)

  Impact: Environmental, Health and wellbeing, Policy, Society and culture, Technological

• Smart inhaler improves adherence to treatment for children with asthma

  Aslam, T. (Participant), Murray, C. (Participant), (Participant) & Murray, I. (Participant)

  Impact: Health and wellbeing

• Standardising Intravenous Infusion Concentrations in Children in the UK

  Sutherland, A. (Corresponding participant)

  Impact: Technological impacts, Health and wellbeing

• Stress management in community pharmacy

  Jacobs, S. (Participant)

  Impact

• Toolkit for commissioners of medicines optimisation services from community pharmacies

  Jacobs, S. (Participant)

  Impact

• Translational Drug Disposition: Enabling the Move Away from One Dose for All

  Rostami-Hochaghan, A. (Participant)

  Impact: Cultural impacts, Economic impacts, Health impacts, Political impacts, Technological impacts